Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Dec 13, 2021
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2021-03-26+135,560→ 1,418,194 total(indirect: Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (1)
- [F1]The reporting person, through its affiliate RGD Investissements S.A.S., acquired the shares of common stock for consideration consisting of the forgiveness and satisfaction of an aggregate of $338,904 of wage liabilities of the Issuer's subsidiaries.